secwatch.observer — SEC 8-K summary
======================================

Issuer:     Estrella Immunopharma, Inc. (ESLA)
CIK:        0001844417
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001213900-25-093197
Event type: regulatory
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Estrella Immunopharma regains Nasdaq compliance on bid price and market value
-----------------------------------------------------------------------------

- Regained compliance with Nasdaq minimum bid price rule (5550(a)(2)) after 10 consecutive days of closing bid ≥ $1.00 (Sept 9-22, 2025).
- Regained compliance with Nasdaq minimum market value of listed securities rule (5550(b)(2)) after 17 consecutive days of MV ≥ $35M (Aug 28-Sept 22, 2025).
- Both compliance matters are now closed; previously disclosed non-compliance resolved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025093197/0001213900-25-093197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844417/000121390025093197/ea0259355-8k_estrella.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-093197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer